{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:06:56Z","timestamp":1780549616872,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T00:00:00Z","timestamp":1740873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["UID\/Multi\/50016\/2019"],"award-info":[{"award-number":["UID\/Multi\/50016\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007434","name":"National Innovation Agency","doi-asserted-by":"publisher","award":["POCI-01-0247-FEDER-027578"],"award-info":[{"award-number":["POCI-01-0247-FEDER-027578"]}],"id":[{"id":"10.13039\/501100007434","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ejpb.2025.114684","type":"journal-article","created":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T09:37:26Z","timestamp":1740908246000},"page":"114684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Breaking the virus: Yeast glucans as an effective alternative to acyclovir in HSVI treatment"],"prefix":"10.1016","volume":"210","author":[{"given":"Diana","family":"Tavares-Valente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio","family":"Conde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Pintado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Azevedo-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejpb.2025.114684_b0005","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.3390\/ijms23063156","article-title":"From cancer therapy to winemaking: the molecular structure and applications of \u03b2-glucans and \u03b2-1, 3-glucanases","volume":"23","author":"Caseiro","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114684_b0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1074-7613(03)00233-4","article-title":"Fungal \u03b2-glucans and mammalian immunity","volume":"19","author":"Brown","year":"2003","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.ejpb.2025.114684_b0015","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1348-0421.1997.tb01959.x","article-title":"Immunomodulatory activities of oat \u03b2\u2010glucan in vitro and in vivo","volume":"41","author":"Estrada","year":"1997","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.ejpb.2025.114684_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/8562309","article-title":"Efficacy of pleuran (\u03b2 -glucan from pleurotus ostreatus) in the management of herpes simplex virus type 1 infection","volume":"2020","author":"Urbancikova","year":"2020","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.ejpb.2025.114684_b0025","doi-asserted-by":"crossref","unstructured":"Seong SK, Kim HW. Potentiation of Innate Immunity by \u03b2-Glucans. Mycobiology. 2010 Jun;38(2):144-8. doi: 10.4489\/MYCO.2010.38.2.144. Epub 2010 Jun 30. PMID: 23956643; PMCID: PMC3741566.","DOI":"10.4489\/MYCO.2010.38.2.144"},{"key":"10.1016\/j.ejpb.2025.114684_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00673","article-title":"The complexity of fungal \u03b2-glucan in health and disease: effects on the mononuclear phagocyte system","volume":"9","author":"Camilli","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114684_b0035","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/jmf.2005.8.154","article-title":"Enhancement of radioprotection and anti-tumor immunity by yeast-derived \u03b2-glucan in mice","volume":"8","author":"Gu","year":"2005","journal-title":"J. Med. Food"},{"key":"10.1016\/j.ejpb.2025.114684_b0040","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijbiomac.2021.02.207","article-title":"Antitumor effect of soluble \u03b2-glucan as an immune stimulant","volume":"179","author":"Wu","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"11","key":"10.1016\/j.ejpb.2025.114684_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224740","article-title":"Synergistic immuno-modulatory activity in human macrophages of a medicinal mushroom formulation consisting of Reishi, Shiitake and Maitake","volume":"14","author":"Mallard","year":"2019","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ejpb.2025.114684_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00114","article-title":"Mechanisms of action of adjuvants","volume":"4","author":"Awate","year":"2013","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114684_b0055","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1586\/erv.11.30","article-title":"Carbohydrate-based immune adjuvants","volume":"10","author":"Petrovsky","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ejpb.2025.114684_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1143682","article-title":"\u03b2-glucans: a potential source for maintaining gut microbiota and the immune system","volume":"10","author":"Singh","year":"2023","journal-title":"Front. Nutr."},{"key":"10.1016\/j.ejpb.2025.114684_b0065","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ijbiomac.2013.07.016","article-title":"Antioxidant capacities of mannans and glucans are related to their susceptibility of free radical degradation","volume":"61","author":"Machov\u00e1","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114684_b0070","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ptr.4963","article-title":"Skin health promotion effects of natural beta\u2010glucan derived from cereals and microorganisms: a review","volume":"28","author":"Du","year":"2014","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ejpb.2025.114684_b0075","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijbiomac.2021.04.169","article-title":"Hydrogel containing (1 \u2192 6)-\u03b2-D-glucan (lasiodiplodan) effectively promotes dermal wound healing","volume":"183","author":"Nissola","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"10","key":"10.1016\/j.ejpb.2025.114684_b0080","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1021\/acs.biomac.2c00156","article-title":"Sulfonated (1 \u2192 6)-\u03b2- <scp>d<\/scp> -glucan (lasiodiplodan): a promising candidate against the acyclovir-resistant herpes simplex virus type 1 (HSV-1) strain","volume":"23","author":"Wouk","year":"2022","journal-title":"Biomacromolecules"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114684_b0085","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/1743-422X-8-481","article-title":"Herpes simplex virus infects most cell types in vitro: clues to its success","volume":"8","author":"Karasneh","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.ejpb.2025.114684_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.00139","article-title":"Current antivirals and novel botanical molecules interfering with herpes simplex virus infection","volume":"11","author":"\u00c1lvarez","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejpb.2025.114684_b0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijbiomac.2018.04.056","article-title":"The antiviral activity of polysaccharides and their derivatives","volume":"115","author":"Chen","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2025.114684_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130933","article-title":"Circular economyeast: Saccharomyces cerevisiae as a sustainable source of glucans and its safety for skincare application","volume":"265","author":"Sousa","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114684_b0105","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jid.2018.08.034","article-title":"A preclinical model for studying herpes simplex virus infection","volume":"139","author":"Tajpara","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejpb.2025.114684_b0110","doi-asserted-by":"crossref","first-page":"394","DOI":"10.37349\/ei.2024.00148","article-title":"Herpes simplex virus-mediated skin infections: cytokines and its interplay","author":"Mukhopadhyay","year":"2024","journal-title":"Explor. Immunol."},{"key":"10.1016\/j.ejpb.2025.114684_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.936235","article-title":"Cytokines and chemokines: The vital role they play in herpes simplex virus mucosal immunology","volume":"13","author":"Smith","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejpb.2025.114684_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112779","article-title":"Effect of squalane-based emulsion on polyphenols skin penetration: Ex vivo skin study","volume":"218","author":"Oliveira","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"4","key":"10.1016\/j.ejpb.2025.114684_b0125","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3390\/jof7040250","article-title":"Effects of medicinal fungi-derived \u03b2-glucan on tumor progression","volume":"7","author":"Vetvicka","year":"2021","journal-title":"J. Fungi"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114684_b0130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1600-065X.2009.00793.x","article-title":"\u03b2\u2010glucan recognition by the innate immune system","volume":"230","author":"Goodridge","year":"2009","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.ejpb.2025.114684_b0135","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3390\/pharmaceutics15061615","article-title":"Immunomodulatory effect and biological significance of \u03b2-glucans","volume":"15","author":"Zhong","year":"2023","journal-title":"Pharmaceutics"},{"issue":"23","key":"10.1016\/j.ejpb.2025.114684_b0140","doi-asserted-by":"crossref","first-page":"12636","DOI":"10.3390\/ijerph182312636","article-title":"\u03b2-Glucans could be adjuvants for SARS-CoV-2 virus vaccines (COVID-19)","volume":"18","author":"C\u00f3rdova-Mart\u00ednez","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"19","key":"10.1016\/j.ejpb.2025.114684_b0145","doi-asserted-by":"crossref","first-page":"10684","DOI":"10.3390\/ijms221910684","article-title":"Trained immunity as an adaptive branch of innate immunity","volume":"22","author":"Vetvicka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ejpb.2025.114684_b0150","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3390\/v15051204","article-title":"\u03b2-glucan induces training immunity to promote antiviral activity by activating TBK1","volume":"15","author":"Wang","year":"2023","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.ejpb.2025.114684_b0155","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/vaccines11020206","article-title":"An insight into current treatment strategies, their limitations, and ongoing developments in vaccine technologies against herpes simplex infections","volume":"11","author":"Sharma","year":"2023","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114684_b0160","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/v15010225","article-title":"A comprehensive overview of epidemiology, pathogenesis and the management of herpes labialis","volume":"15","author":"Gopinath","year":"2023","journal-title":"Viruses"},{"issue":"24","key":"10.1016\/j.ejpb.2025.114684_b0165","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.2174\/0929867325666180309105519","article-title":"Acyclovir in the treatment of herpes viruses \u2013 a review","volume":"27","author":"K\u0142ysik","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejpb.2025.114684_b0170","doi-asserted-by":"crossref","DOI":"10.1177\/20587384211002621","article-title":"A review: mechanism of action of antiviral drugs","volume":"35","author":"Kausar","year":"2021","journal-title":"Int. J. Immunopath. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejpb.2025.114684_b0175","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1468-2494.2008.00470.x","article-title":"Chitin\u2013glucan, a natural cell scaffold for skin moisturization and rejuvenation","volume":"30","author":"Gautier","year":"2008","journal-title":"Int. J. Cosmet. Sci."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125000608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125000608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T22:50:02Z","timestamp":1753743002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125000608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":35,"alternative-id":["S0939641125000608"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114684","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breaking the virus: Yeast glucans as an effective alternative to acyclovir in HSVI treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114684"}}